| Financial Year |
March 31 2023 |
| Monetary Funds |
603,361,085.16 |
| Held-for-trading Financial Assets |
60,090,559.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
52,553,678.67 |
| Advances to Suppliers |
131,391,464.08 |
| Other Receivables |
55,935,109.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,231,739,738.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,689,591.35 |
| Total Current Assets |
2,169,761,226.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,537,406.89 |
| Fixed Assetes |
2,153,594,813.68 |
| Under-construction Projects |
264,249,094.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
177,937,511.34 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,150,109.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
77,877,785.54 |
| Deferred Income Tax Assets |
8,312,498.73 |
| Other Non-Current Assets |
35,677,402.89 |
| Sub-Total of Non-Current Assets |
3,127,635,380.73 |
| Total Assets |
5,297,396,607.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
369,995,905.39 |
| Accounts Received In Advance |
2,303,295.28 |
| Employee Compensation Payable |
23,775,068.94 |
| Taxes Payable |
3,609,945.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
133,232,026.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,675,577.32 |
| Other Current Liabilities |
5,193,331.64 |
| Sub-Total of Current Liabilities |
558,653,420.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,896,805.62 |
| Deferred Income Tax Liabilities |
1,035.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
155,531,304.60 |
| Total Liabilities |
714,184,725.00 |
| Paid-In Capital(Or Share Stock) |
524,304,516.00 |
| Capital Surplus |
2,032,901,801.20 |
| Surplus Reserve |
155,052,259.47 |
| LESS:Treasury Stock |
55,974,996.00 |
| Undistributed Profits |
1,926,928,301.87 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,583,211,882.54 |
| Owner's Equity（Stockholder's Equity） |
4,583,211,882.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,297,396,607.54 |
